Detalhe da pesquisa
1.
Control of disease activity with large extended-interval dosing of rituximab/ocrelizumab in highly active pediatric multiple sclerosis.
Mult Scler
; 30(2): 261-265, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38166437
2.
COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022.
Mult Scler
; 30(3): 381-395, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38247113
3.
The radiologically isolated syndrome: revised diagnostic criteria.
Brain
; 146(8): 3431-3443, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36864688
4.
Impact of COVID-19 vaccination or infection on disease activity in a radiologically isolated syndrome cohort: The VaxiRIS study.
Mult Scler
; 29(9): 1099-1106, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37322880
5.
Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring system.
Mult Scler
; 29(2): 236-247, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36515394
6.
Pregnancy and multiple sclerosis: 2022 recommendations from the French multiple sclerosis society.
Mult Scler
; 29(1): 11-36, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36317497
7.
Pregnancy and neuromyelitis optica spectrum disorders: 2022 recommendations from the French Multiple Sclerosis Society.
Mult Scler
; 29(1): 37-51, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36345839
8.
TNF-α inhibitors used as steroid-sparing maintenance monotherapy in parenchymal CNS sarcoidosis.
J Neurol Neurosurg Psychiatry
; 2021 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34103339
9.
Untreated patients with multiple sclerosis: A study of French expert centers.
Eur J Neurol
; 28(6): 2026-2036, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33650261
10.
A Multidimensional Assessment of Metacognition Across Domains in Multiple Sclerosis.
J Int Neuropsychol Soc
; 27(2): 124-135, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32772949
11.
A proliferation-inducing ligand-mediated anti-inflammatory response of astrocytes in multiple sclerosis.
Ann Neurol
; 85(3): 406-420, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30635946
12.
The role of APRIL - A proliferation inducing ligand - In autoimmune diseases and expectations from its targeting.
J Autoimmun
; 95: 179-190, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30385081
13.
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis.
JAMA Neurol
; 81(3): 273-282, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38345791
14.
The diagnostic workup of children with the radiologically isolated syndrome differs by age and by sex.
J Neurol
; 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38564056
15.
High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS.
JAMA Neurol
; 81(5): 490-498, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38526462
16.
Immune Profiling Reveals the T-Cell Effect of Ocrelizumab in Early Relapsing-Remitting Multiple Sclerosis.
Neurol Neuroimmunol Neuroinflamm
; 10(3)2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36810163
17.
Association Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple Sclerosis.
JAMA Netw Open
; 6(6): e2319766, 2023 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37351881
18.
Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis: A Large Multicenter Cohort Study.
Neurol Neuroimmunol Neuroinflamm
; 10(1)2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36376096
19.
Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal Inference.
Neurology
; 100(12): e1296-e1308, 2023 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36564207
20.
Rituximab in refractory and non-refractory myasthenia: a retrospective multicenter study.
Muscle Nerve
; 46(5): 687-91, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22941747